期刊文献+

低分子肝素治疗急性冠脉综合症的临床试验分析 被引量:6

下载PDF
导出
摘要 本文对低分子肝素治疗急性冠脉综合症的三个临床试验 (FRAXIS ,FRIC ,ESSENCE)进行了分析与评价 。
作者 张梅
出处 《实用心脑肺血管病杂志》 2002年第1期45-52,共8页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献14

  • 1[1]Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.J Am Coll Cardiol.1995,26:313~318.
  • 2[2]Fragmin During Instability in Coronary Artery Disease(FRISC) study group.Low molecular weight heparin during instability in CAD.Lancet.1996,347:561~568.
  • 3[3]FRAX.I.S study group.Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction:FRAX.I.S.(FRAxiparine in Ischaemic Syndrome).Eur Heart J.1999,20(21):1553~1562.
  • 4[4]Klein W,Buchwald A,Hillis SE,et al.Comparison of low molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease.Fragmin in unstable coronary artery disease study (FRIC).Circulation.1997,96:61~68.
  • 5[5]Cohen M,Demers C,Gurfinkel FP,et al.A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease.N Ehgl J Med.1997,337:447~452.
  • 6[6]Antman EM,Mcgabe CH,Gurfinkel EP,et al.For the TIMI 11B Investigators.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non Q-wave myocardial infarction:results of the thrombolysis in myocardial infarction (TIMI) 11B trial.Circulation.1999,100:1593~1601.
  • 7[7]Fragmin and fast revascularization during instability in coronary artery disease (FRISC Ⅱ) investigators.Long-term low molecular mass heparin in unstable coronary artery disease:FRISC Ⅱ prospective randomized multicentre study.Fragmin and fast revascularisation during instability in coronary artery disease.Investigators.Lancet.1999,354:701~707.
  • 8[8]Weita JI.Low-molecular-weight heparins.N Engl J Med.1997,338:688~698.
  • 9[9]Samama MM,Bara L,Gouin-Thibault.New data on the pharmacology of heparin and low molecular weight heparins.Drugs.1996,52(7):8~15.
  • 10[10]Monrad ES.Role of low molecular weight heparins in the management of patients with unstable angina pectoris and non Q wave acute myocardial infarction.Am J Cardiol.2000,85:2C~9C.

同被引文献27

引证文献6

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部